DCGI

Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The PipelineBhaswati Guha Majumder Oct 13, 2021 07:30 AM
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On Children
Hyderabad-Based Biological E Gets DCGI Nod To Conduct Phase 2/3 Clinical Trials Of Its COVID-19 Vaccine On ChildrenIANSSep 2, 2021 07:15 AM
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical Trials
India's First mRNA COVID Vaccine Candidate Found To Be Safe, Gets DCGI Nod For Phase 2/3 Clinical TrialsSwarajya StaffAug 25, 2021 05:30 AM
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In IndiaSwarajya StaffAug 20, 2021 07:36 AM
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's Vellore
DCGI Approves Study On Mixing Of Covaxin, Covishield Vaccines; Clinical Trial To Begin In Tamil Nadu's VelloreSwarajya StaffAug 11, 2021 06:15 AM
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 10:44 AM
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In India
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In IndiaSwarajya StaffAug 6, 2021 03:59 AM
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In Trials
DCGI's Expert Panel Gives Go-Ahead To Bharat Biotech For Mixing Of COVAXIN And Nasal COVID-19 Vaccine In TrialsSwarajya StaffJul 31, 2021 05:11 AM
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: Report
DCGI's Expert Panel To Take Up Zydus Cadila's Application For Emergency Use Approval To Its COVID-19 Jab This Week: ReportSwarajya StaffJul 7, 2021 06:12 AM
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data FirstSwarajya StaffJul 1, 2021 08:52 AM
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: Report
US-Based Moderna Seeks DCGI Approval For Its mRNA COVID-19 Vaccine In India: ReportSwarajya StaffJun 29, 2021 09:13 AM
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 Patients
DCGI Approves Phase 2 Clinical Trial Of Repurposed Drug 'Colchicine' On COVID-19 PatientsSwarajya StaffJun 12, 2021 08:33 AM
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In India
Serum Institute Seeks DCGI Nod For License To Manufacture Russian Sputnik V Covid-19 Vaccine In IndiaSwarajya StaffJun 3, 2021 07:34 AM
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: Report
DCGI Studying Use Of Alternate Drugs Other Than Amphotericin B To Treat Mucormycosis: ReportSwarajya StaffJun 2, 2021 06:31 AM
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas Regulators
India's Drug Regulator DCGI Exempts Local Bridging Trials For Foreign Vaccines Approved By WHO And Select Overseas RegulatorsSwarajya StaffJun 2, 2021 05:31 AM
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19
Zydus Cadila Seeks DCGI's Approval For Conducting Clinical Trials Of Antibody Cocktail To Treat Mild COVID-19Swarajya StaffMay 27, 2021 06:59 AM
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: Report
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: ReportSwarajya StaffMay 14, 2021 09:00 AM
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: Report
Bharat Biotech's Covaxin Recommended By DCGI's Expert Panel For Phase 2 And 3 Trial On 2 To 18 Years Old: ReportSwarajya StaffMay 12, 2021 03:12 AM
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers 
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers Bhaswati Guha Majumder May 10, 2021 05:28 AM
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 Patients
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 PatientsSwarajya StaffMay 8, 2021 09:46 AM
Load More